Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937-2013

Journal of the Pediatric Infectious Diseases Society

Volumn 4, Issue 4, 2015, Pages e68-e75

  Capewell, Linda G ^a,b   Harris, Aaron M ^a   Yoder, Jonathan S ^b   Cope, Jennifer R ^b   Eddy, Brittany A ^b   Roy, Sharon L ^b   Visvesvara, Govinda S ^b   Fox, LeAnne M ^a   Beach, Michael J ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Amoebic meningoencephalitis diagnosis and treatment; Naegleria infection; Water borne disease

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE; MICONAZOLE; RIFAMPICIN; STEROID;

ADOLESCENT; ADULT; AGED; AMEBIC INFECTION; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; DISEASE COURSE; FEMALE; FLU LIKE SYNDROME; HEALTH CARE FACILITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NAEGLERIA FOWLERI; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIMARY AMEBIC MENINGOENCEPHALITIS; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; WATER BORNE DISEASE; YOUNG ADULT; AMEBIASIS; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; CEREBROSPINAL FLUID; EPIDEMIOLOGY; MIDDLE AGED; PARASITOLOGY;

ADOLESCENT; ADULT; AGED; AMEBIASIS; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NAEGLERIA FOWLERI; UNITED STATES; YOUNG ADULT;

EID: 85006200920     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu103     Document Type: Article

References (32)

1. Yoder J, Eddy B, Visvesvara G, Capewell L, Beach M. The epidemiology of primary amoebic meningoencephalitis in the USA, 1962-2008. Epidemiol Infect 2010; 138:968-75.
2. Kemble SK, Lynfield R, DeVries AS, et al. Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism. Clin Infect Dis 2012; 54: 805-9.
3. Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 2007; 50:1-26.
4. Martinez J, Duma R, Nelson E, Moretta F. Experimental Naegleria meningoencephalitis in mice. Penetration of the olfactory mucosal epithelium by Naegleria and pathologic changes produced: a light and electron microscope study. Lab Invest 1973; 29:121-33.
5. Visvesvara G, Callaway C. Light and electron microsopic observations on the pathogenesis of Naegleria fowleri in mouse brain and tissue culture. J Eukaryot Microbiol 1974; 21:239-50.
6. Das S. Pathogenicity of flagellate stage of Naegleria aerobia and its bearing on the epidemiology of exogenous amoebiasis. Ann Soc Belge Med Trop 1974; 54:327-32.
7. Ma P, Visvesvara GS, Martinez AJ, et al. Naegleria and Acanthamoeba infections: review. Rev Infect Dis 1990; 12: 490-513.
8. Barnett ND, Kaplan AM, Hopkin RJ, Saubolle MA, Rudinsky MF. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review. Pediatr Neurol 1996; 15:230-4.
9. Okuda DT, Hanna HJ, Coons SW, Bodensteiner JB. Naegleria fowleri hemorrhagic meningoencephalitis: report of two fatalities in children. J Child Neurol 2004; 19:231-3.
10. Qvarnstrom Y, Visvesvara GS, Sriram R, da Silva AJ. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol 2006; 44:3589-95.
11. American Academy of Pediatrics. Amebic meningoencephalitis and keratitis; p.225-7. In: Pickering L, ed. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012.
12. Okuda DT, Coons S. Naegleria fowleri meningoencephalitis. Neurology 2003; 61:E1.
13. Hecht R, Cohen A, Stoner J, Irwin C. Primary amebic meningoencephalitis in California. Calif Med 1972; 117:69-73.
14. Lopez C, Budge P, Chen J, et al. Primary amebic meningoencephalitis: a case report and literature review. Pediatr Emerg Care 2012; 28:272-6.
15. Stephany JD, Pearl GS, Gonzalez OR. Pathologic quiz case: headache in an 8-year-old child. Arch Pathol Lab Med 2004; 128: e33-4.
16. Seidel JS, Harmatz P, Visvesvara G, et al. Successful treatment of primary amebic meningoencephalitis. N Engl J Med 1982; 306:346-8.
17. Vargas-Zepeda J, Gómez-Alcalá AV, Vázquez-Morales JA, et al. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res 2005; 36:83-6.
18. Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34:1001-27.
19. Thong Y, Rowan-Kelly B, Shepherd C, Ferrante A. Growth inhibition of Naegleria fowleri by tetracycline, rifamycin, and miconazole. Lancet 1977; 310(8043):876.
20. Food and Drug Administration. Drug approval package: Ambisome (amphotericin B). Available at: http://www.accessdata. fda.gov/drugsatfda_docs/nda/97/050740_ambisome_toc.cfm. Accessed October 14, 2014.
21. Wingard JR, White MH, Anaissie E, et al. A randomized, doubleblind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 2000; 31:1155-63.
22. Goswick SM, Brenner GM. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. J Parasitol 2003; 89:837-42.
23. Goswick SM, Brenner GM. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother 2003; 47:524-8.
24. Kim J-H, Jung S-Y, Lee Y-J, et al. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri. Antimicrob Agents Chemother 2008; 52:4010-6.
25. Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol 2006; 53:121-6.
26. Aichelburg AC, Walochnik J, Assadian O, et al. Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine. Emerg Infect Dis 2008; 14:1743-6.
27. Martinez DY, Seas C, Bravo F, et al. Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin InfectDis 2010; 51:e7-11.
28. Centers for Disease Control and Prevention. Investigational drug available directly from CDC for the treatment of infections with freeliving amebae. MMWR Morb Mortal Wkly Rep 2013; 62:666.
29. Soltow SM, Brenner GM. Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother 2007; 51:23-7.
30. Shirlyn B, McKenzie P. Clinical Laboratory Hematology, 2nd ed. Upper Saddle River, NJ: Pearson Education, Inc, 2010.
31. The Merck Manual of Diagnosis and Therapy, 19th ed. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 2011.
32. McPherson RA, Pincus MR. Henry's clinical diagnosis and management by laboratory methods, 22nd ed. Philadelphia, PA: Elsevier Health Sciences; 2011.